GSK3B and osteosarcoma: found that DMY executes anti-tumor effects through the induction of apoptosis in osteosarcoma cells and the potential mechanism may be due to the activation of p38MAPK and AMPKα/GSK-3β/Sox2 signaling pathway (71).